UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epigenetic Targeting of Glioblastoma

Frontiers in oncology, 2018-10, Vol.8, p.448-448

2018

Volltextzugriff (PDF)

Immune Checkpoints and Innovative Therapies in Glioblastoma

Frontiers in oncology, 2018-10, Vol.8, p.464-464

2018

Volltextzugriff (PDF)

MicroRNA in Glioblastoma: An Overview

International journal of genomics, 2017-01, Vol.2017 (2017), p.1-16

2017

Volltextzugriff (PDF)

Small molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cells

Oncotarget, 2017-05, Vol.8 (21), p.34896-34910

2017

Volltextzugriff (PDF)

CTLA‐4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction

International journal of cancer, 2005-11, Vol.117 (4), p.538-550

2005

Volltextzugriff (PDF)

Mesothelin in serum and pleural effusion in the diagnosis of malignant pleural mesothelioma with non-positive cytology

Anticancer research, 2014-12, Vol.34 (12), p.7425

2014

Volltextzugriff (PDF)

Detection of Circulating Tumour Cells in Breast Cancer Patients Using Human Mammaglobin RT-PCR: Association with Clinical Prognostic Factors

Anticancer research, 2010-06, Vol.30 (6), p.2377-2382

2010

Volltextzugriff (PDF)

Pilot Study to Evaluate Serum Soluble Mesothelin-Related Peptide (SMRP) as Marker for Clinical Monitoring of Pleural Mesothelioma (PM): Correlation with Modified RECIST Score

Diagnostics (Basel), 2021-10, Vol.11 (11), p.2015

2021

Volltextzugriff (PDF)

EGFR Status in Mesothelioma: Possible Implications for the Efficacy of Anti-EGFR and Anti-MET Therapies

Journal of thoracic oncology, 2016-06, Vol.11 (6), p.e78-e80

2016

Volltextzugriff (PDF)

Environmental Epigenetics: Crossroad between Public Health, Lifestyle, and Cancer Prevention

BioMed research international, 2015-01, Vol.2015 (2015), p.1-13

2015

Volltextzugriff (PDF)

Targeting of Histone Demethylases KDM5A and KDM6B Inhibits the Proliferation of Temozolomide-Resistant Glioblastoma Cells

Cancers, 2019-06, Vol.11 (6), p.878

2019

Volltextzugriff (PDF)

Patients with neoplastic and nonneoplastic hematologic diseases acquire CTLA-4 antibodies after blood transfusion

Transfusion (Philadelphia, Pa.), 2001-04, Vol.41 (4), p.462-469

2001

Volltextzugriff (PDF)

Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma

Cancer Immunology, Immunotherapy, 2014-07, Vol.63 (7), p.675-683

2014

Volltextzugriff (PDF)

Analysis and clinical relevance of human leukocyte antigen class I, heavy chain, and β2-microglobulin downregulation in breast cancer

Human immunology, 2009-07, Vol.70 (7), p.492-495

2009

Volltextzugriff (PDF)

The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production

Journal of translational medicine, 2013-05, Vol.11 (1), p.108-108, Article 108

2013

Volltextzugriff (PDF)

Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer

Cancer Immunology, Immunotherapy, 2012-09, Vol.61 (9), p.1463-1472

2012

Volltextzugriff (PDF)

Association between PD-1 single nucleotide gene variants and the risk of metastatic melanoma

Archives of Dermatological Research, 2024-06, Vol.316 (7), p.414, Article 414

2024

Volltextzugriff (PDF)

Phenotypic characterization of tumor CTLA-4 expression in melanoma tissues and its possible role in clinical response to Ipilimumab

Clinical immunology (Orlando, Fla.), 2020-06, Vol.215, p.108428-108428, Article 108428

2020

Volltextzugriff (PDF)

IFN-γ upregulates membranous and soluble PD-L1 in mesothelioma cells: potential implications for the clinical response to PD-1/PD-L1 blockade

Cellular & molecular immunology, 2020-04, Vol.17 (4), p.410-411

2020

Volltextzugriff (PDF)

Determination of Mesothelin Levels in Pleural Effusion Does Not Help Predict Survival of Patients With Malignant Pleural Mesothelioma

Anticancer research, 2019-09, Vol.39 (9), p.5219-5223

2019

Volltextzugriff (PDF)

Epigenetic dysregulation in neuroblastoma: A tale of miRNAs and DNA methylation

Biochimica et biophysica acta, 2016-12, Vol.1859 (12), p.1502-1514

2016

Volltextzugriff (PDF)

The Correlation of Serum Mesothelin Level With Pleural Thickness in Malignant Pleural Mesothelioma Makes it a Valuable Tool for Monitoring Tumor Progression

Journal of thoracic oncology, 2019-05, Vol.14 (5), p.e92-e94

2019

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(77)

Publikationsform

Sprache

Englisch
(85)
Italienisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Epigenetic Targeting of Glioblastoma

Immune Checkpoints and Innovative Therapies in Glioblastoma

MicroRNA in Glioblastoma: An Overview

Small molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cells

CTLA‐4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction

Mesothelin in serum and pleural effusion in the diagnosis of malignant pleural mesothelioma with non-positive cytology

Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study

Detection of Circulating Tumour Cells in Breast Cancer Patients Using Human Mammaglobin RT-PCR: Association with Clinical Prognostic Factors

Pilot Study to Evaluate Serum Soluble Mesothelin-Related Peptide (SMRP) as Marker for Clinical Monitoring of Pleural Mesothelioma (PM): Correlation with Modified RECIST Score

EGFR Status in Mesothelioma: Possible Implications for the Efficacy of Anti-EGFR and Anti-MET Therapies

Corrigendum: Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study

Environmental Epigenetics: Crossroad between Public Health, Lifestyle, and Cancer Prevention

Targeting of Histone Demethylases KDM5A and KDM6B Inhibits the Proliferation of Temozolomide-Resistant Glioblastoma Cells

Patients with neoplastic and nonneoplastic hematologic diseases acquire CTLA-4 antibodies after blood transfusion

Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma

Analysis and clinical relevance of human leukocyte antigen class I, heavy chain, and β2-microglobulin downregulation in breast cancer

The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production

Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study

Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer

Association between PD-1 single nucleotide gene variants and the risk of metastatic melanoma

Phenotypic characterization of tumor CTLA-4 expression in melanoma tissues and its possible role in clinical response to Ipilimumab

IFN-γ upregulates membranous and soluble PD-L1 in mesothelioma cells: potential implications for the clinical response to PD-1/PD-L1 blockade

Determination of Mesothelin Levels in Pleural Effusion Does Not Help Predict Survival of Patients With Malignant Pleural Mesothelioma

Epigenetic dysregulation in neuroblastoma: A tale of miRNAs and DNA methylation

The Correlation of Serum Mesothelin Level With Pleural Thickness in Malignant Pleural Mesothelioma Makes it a Valuable Tool for Monitoring Tumor Progression

Suchergebnisse filtern